Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
BioAgilytix to Purchase Australia-based 360biolabs® 2021-08-16 18:00
Senhwa Completes Enrollment of a Phase 2 Investigator Initiated Trial of Silmitasertib as Novel Oral Drug for COVID-19 2021-08-16 15:29
Qiming's Portfolio Company Sino Biological Lists on Shenzhen's ChiNext Market 2021-08-16 14:14
Sino Biological Announces Successful Closing of 4.98 Billion RMB Public Offering and Listing on the Shenzhen ChiNext Stock Exchange 2021-08-16 13:12
GeneQuantum announces a key leadership appointment 2021-08-16 10:00
InxMed's IN10018 Receives U.S. FDA Fast Track Designation for the Treatment of Platinum-resistant Ovarian Cancer 2021-08-16 09:31
Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and India 2021-08-16 08:00
TurtleTree and Solar Biotech enter strategic partnership 2021-08-13 21:00
A3P Biomedical AB: Fast track publication of the STHLM3 MRI trial in The Lancet Oncology 2021-08-13 12:22
TOT BIOPHARM Anounces 2021 Interim Results 2021-08-13 10:59
WuXi AppTec Reports Strong 2021 Interim Results 2021-08-12 17:52
NUHS Embarks on Holomedicine Research in Singapore, Using Mixed Reality Technology to Enhance Diagnosis, Education and Patient Care 2021-08-12 15:00
Innovent Announces IBI306 (anti-PCSK-9 antibody) Meets the Primary Endpoint in a Phase 3 Clinical Study for Chinese Heterozygous Familial Hypercholesterolemia 2021-08-12 08:00
Lynk Pharmaceuticals Announced First Patient Dosed in Phase I Clinical Study of Its Triple-Kinase Inhibitor LNK01002 2021-08-12 08:00
The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director 2021-08-11 20:31
Technology Investments will Help Oncology Practices Succeed in Value-based Care 2021-08-11 18:02
ImmVira's MVR-T3011 IV Completed First Dosing for Intravenous Administration in a U.S. Phase I Clinical Trial 2021-08-11 10:45
INDICAID(TM) COVID-19 Rapid Antigen Test Receives Emergency Use Authorization From the U.S. Food and Drug Administration 2021-08-11 01:00
Belief Biomed's Gene Therapy for Hemophilia B Receives NMPA IND Approval: First Intravenous Infusion Gene Therapy for Rare Disease in China 2021-08-10 23:39
INDICAID(TM) COVID-19 Rapid Antigen Test Receives Emergency Use Authorization from the U.S. Food and Drug Administration 2021-08-10 22:00
1 228 229 230 231 232 452